BioNTech SE (BNTX) vs United Therapeutics Corporation (UTHR)

A side-by-side comparison of BioNTech SE and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Compare
BioNTech SE logo
BNTX
BioNTech SE
$23.38B
$92.45HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
United Therapeutics Corporation logo
UTHR
United Therapeutics Corporation
$22.23B
$523.63HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — BNTX vs UTHR

growth of $100 · dividends reinvested · last 7y
BNTX +548.2%UTHR +570.7%UTHR compounded faster
01k2k3kStart $100202120232025$648$671
BNTX UTHR

BNTX vs UTHR: by the numbers

  • •BNTX is the larger company ($23.38B vs $22.23B market cap).
  • •UTHR is profitable (40.61% net margin) while BNTX runs a net loss (-44.73%).
  • •UTHR grew revenue faster over the past five years (16.05% vs 2.16% CAGR).

Metrics side by side

Valuation

MetricBNTXUTHR
P/E ratioN/A19.52
Forward P/EN/A18.94
P/S ratio7.017.86
P/B ratio1.074.22
PEG ratioN/A1.16
EV / EBITDAN/A15.63
FCF yield6.49%4.08%

Profitability

MetricBNTXUTHR
Gross margin73.26%86.58%
Operating margin-22.63%45.34%
Net margin-44.73%40.61%
ROE-6.79%21.82%
ROIC-3.14%16.13%

Growth (annualized)

MetricBNTXUTHR
Revenue CAGR (5Y)2.16%16.05%
EPS CAGR (5Y)N/A20.93%
FCF CAGR (5Y)N/A12.12%
Total return CAGR (5Y)-20.13%23.16%

Frequently asked

Which has grown faster, BNTX or UTHR?
Over the past five years, UTHR grew revenue faster — BNTX at a 2.16% CAGR versus UTHR at 16.05%.
Is BNTX or UTHR more profitable?
UTHR runs the higher net margin — BNTX at -44.73% versus UTHR at 40.61%.
How have BNTX and UTHR total returns compared?
Over the past 5 years, BNTX delivered -20.13% and UTHR delivered 16.65% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BNTX analysisFull UTHR analysisInteractive comparison tool

Dig into the metrics

BioNTech SE P/E ratioUnited Therapeutics P/E ratioBioNTech SE dividend yieldUnited Therapeutics dividend yieldBioNTech SE ROEUnited Therapeutics ROEBioNTech SE operating marginUnited Therapeutics operating marginBioNTech SE revenue growthUnited Therapeutics revenue growthBioNTech SE free cash flowUnited Therapeutics free cash flow

BioNTech SE & United Therapeutics appear in these rankings

Fastest Revenue Growth StocksHighest Operating Margin StocksHighest FCF Yield StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.